ARN-509選擇性與競爭性之AR抑制劑 | Biovision貨號: 9535-25

| 代理廠牌: | ![]() |
| 原廠連結: | |
| 相關下載: |
特點
Androgen Receptor Antagonists抑制劑 | ARN-509抑制劑 | 貨號: 9535-25
A selective and competitive androgen receptor (AR) inhibitor
ARN-509是一種選擇性的與競爭性之雄激素受體(AR)抑制劑(IC 50= 16 nM)。ARN-509選擇性地結合雄激素受體和損害其核轉位及DNA結合作用,為前列腺癌的治療中有用之雄激素反應的元素。
ARN-509 is a selective and competitive androgen receptor (AR) inhibitor (IC₅₀ = 16 nM). ARN-509 selectively binds the androgen receptor and impairs its nuclear translocation and DNA binding to androgen response elements useful for prostate cancer treatment.
Molecular Formula: C₂₁H₁₅F₄N₅O₂S
Molecular Weight: 477.43
Purity: ≥98% by HPLC
Solubility: DMSO (>5 mg/ml)
| Catalog # | Product Name+ | Size |
| 9535-5 | ARN-509 | 5 mg |
| 9535-25 | ARN-509 | 25 mg |
| 9479-10 | MDV-3100 | 10 mg |
| 9479-50 | MDV-3100 | 50 mg |
| 9668-5 | ODM-201 | 5 mg |
| 9668-25 | ODM-201 | 25 mg |
更多酵素型抑制劑商品: ACE抑制劑類 | AR抑制劑類 | AKR抑制劑類 | adenylyl cyclase 抑制劑類 | AAC抑制劑 | ACAT抑制劑

